Biotech and pharmaceutical sector's "emerging pillar industry" status boosted, Hang Seng Biotech ETF Guotai (520930) surges over 3% intraday

Biopharmaceuticals’ status as an emerging pillar industry is being elevated. On March 17, Hang Seng Biotech ETF Guotai (520930) surged over 3% intraday.

Industrial Securities pointed out that this year’s government work report proposed “implementing an industrial innovation project” and focused on developing biopharmaceuticals as an emerging pillar industry. This is the first time the biopharmaceutical industry has been given the strategic positioning of a “pillar industry” in top-level national planning. Regarding industry strategy, “innovation + internationalization” will remain the core theme. China’s innovative drugs have advantages in high efficiency and low-cost development, with competitive edges in hot technology tracks such as ADC and bispecific antibodies. The prosperity of the innovative drug industry chain continues to rise, and based on investment and financing data, orders, and performance, the current recovery trend is relatively certain.

The Hang Seng Biotech Index focuses on the “crown jewel” of innovative drugs, offering three major advantages: “leading companies gathering, scarce futures liquidity, high elasticity & high Sharpe ratio.” Investors wishing to conveniently participate in core innovative drug leaders can focus on the Hang Seng Biotech ETF Guotai (520933) for one-click deployment.

Risk reminder: Mentioning individual stocks is only for industry event analysis and does not constitute any stock recommendation or investment advice. Short-term index fluctuations are for reference only and do not predict future performance, nor do they constitute a promise or guarantee of fund performance. Views may change with market conditions and do not constitute investment advice or guarantees. Different funds have different risk-return profiles; investors are advised to carefully read the fund legal documents, fully understand product features, risk levels, and income distribution principles, and choose products that match their risk tolerance. Invest cautiously.

Daily Economic News

(Editor: He Chong)

【Disclaimer】This article only reflects the author’s personal views and is not related to Hexun.com. Hexun.com maintains neutrality regarding the statements and opinions in this article and does not provide any explicit or implicit guarantees regarding the accuracy, reliability, or completeness of the content. Readers are advised to use it for reference only and bear all responsibilities themselves. Email: news_center@staff.hexun.com